Analystreport

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. They now have a $590.00 price targ

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com